Taylor Stacy L 4
4 · Adaptive Biotechnologies Corp · Filed Sep 9, 2021
Insider Transaction Report
Form 4
Taylor Stacy L
SVP and General Counsel
Transactions
- Sale
Common Stock
2021-09-07$40.00/sh−495$19,800→ 15,036 total - Exercise/Conversion
Common Stock
2021-09-07$6.55/sh+495$3,242→ 15,531 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-09-07−495→ 15,443 totalExercise: $6.55Exp: 2028-04-24→ Common Stock (495 underlying)
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020.
- [F2]The options vested with respect to 1/4 of such shares on March 12, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.